Found: 14
Select item for more details and to access through your institution.
Ethnic Differences in Insulin Sensitivity, [beta]-Cell Function, and Hepatic Extraction Between Japanese and Caucasians: A Minimal Model Analysis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Exposure‐response analysis for evaluation of semaglutide dose levels in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2238, doi. 10.1111/dom.13358
- By:
- Publication type:
- Article
Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population.
- Published in:
- Journal of Diabetes Investigation, 2022, v. 13, n. 4, p. 652, doi. 10.1111/jdi.13716
- By:
- Publication type:
- Article
Combined reversed phase and anion exchange solid phase extraction for the assay of the neuroprotectant NBQX in human plasma and urine.
- Published in:
- Biomedical Chromatography, 1993, v. 7, n. 3, p. 166, doi. 10.1002/bmc.1130070314
- By:
- Publication type:
- Article
Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Modeling of 24-hour glucose and insulin profiles in patients with type 2 diabetes mellitus treated with biphasic insulin aspart.
- Published in:
- Journal of Clinical Pharmacology, 2014, v. 54, n. 7, p. 809, doi. 10.1002/jcph.270
- By:
- Publication type:
- Article
Dosing Rationale for Liraglutide in Type 2 Diabetes Mellitus: A Pharmacometric Assessment.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 12, p. 1815, doi. 10.1177/0091270011430504
- By:
- Publication type:
- Article
Population Pharmacokinetics of Liraglutide, a Once-Daily Human Glucagon-Like Peptide-1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice-Daily Exenatide.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 8, p. 886, doi. 10.1177/0091270009354996
- By:
- Publication type:
- Article
Safety and Pharmacokinetics of ReN1869: A First Human Dose Study in Healthy Subjects after Single-Dose Administration.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 1, p. 66, doi. 10.1177/0091270002239708
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 10, p. 1335, doi. 10.1007/s40262-021-01025-x
- By:
- Publication type:
- Article
Population Pharmacokinetics of Semaglutide for Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 2, p. 649, doi. 10.1007/s13300-019-0581-y
- By:
- Publication type:
- Article
Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians.
- Published in:
- Diabetes Care, 2014, v. 37, n. 3, p. 796, doi. 10.2337/dc13-0598
- By:
- Publication type:
- Article
Mathematical Modelling of Glucose-Dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 following Ingestion of Glucose.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2017, v. 121, n. 4, p. 290, doi. 10.1111/bcpt.12792
- By:
- Publication type:
- Article